Advantage of Scheduled Upfront Lenvatinib Administration Followed by Transarterial Chemoembolization Therapy Over Lenvatinib Monotherapy in Patients With Unresectable Intermediate‐Stage Hepatocellular Carcinoma: A Multicenter Cohort Study. - Taniki, Nobuhito; Ojiro, Keisuke; Kasuga, Ryosuke; Nakadai, Yukie; Tabuchi, Takaya; Chu, Po‐Sung; Usui, Shingo; Hoshi, Hitomi; Kaneko, Fumihiko; Yamaguchi, Akihiro; Koizumi, Jun; Ebinuma, Hirotoshi; et al. (Cancer Medicine, 2026)